EnjoSim, a Shanghai-based developer of microbiologic self-administration systems, has reportedly secured tens of millions of renminbi in a Pre-Series A financing round. The funds will be directed towards scaling up the operation of multiple fully automatic production lines, developing new products, and expanding the company’s business reach both within China and internationally.
EnjoSim specializes in high-precision pen injection devices that are compatible with a range of biological agents, including insulin, GLP-1, growth hormone, and follicle stimulating hormone. The company operates a large-scale industrial chemical plant in Wuxi, Jiangsu, which spans thousands of square meters and includes a 100,000-level purification assembly workshop and a closed assembly workshop, reflecting its commitment to precision and quality in manufacturing.- Flcube.com
